Appointment booking for Dr. Michael Piansky, MD is currently not available.Dr. Michael Piansky, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Michael Piansky, MD is a Internist in Austell, GA with over 18 years of experience. What is your opinion of Dr. Michael Piansky, MD? Rate this provider below so other people can make informed decision.
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Michael Piansky, MD has received over $7,402 which includes payments from the following companies:
$1,406.88 from AstraZeneca Pharmaceuticals LP
$824.26 from Novo Nordisk Inc
$658.72 from Amgen Inc.
$550.85 from Astellas Pharma US Inc
$534.90 from LILLY USA, LLC
$403.98 from Janssen Pharmaceuticals, Inc
$388.94 from Pfizer Inc.
$376.83 from Merck Sharp & Dohme Corporation
$371.24 from Boehringer Ingelheim Pharmaceuticals, Inc.
$336.05 from GlaxoSmithKline, LLC.
$297.88 from sanofi-aventis U.S. LLC
$221.95 from AbbVie, Inc.
$190.49 from Takeda Pharmaceuticals America, Inc.
$125.00 from COMSORT, Inc
$114.31 from Daiichi Sankyo Inc.
$103.91 from Eisai Inc.
$69.72 from Arbor Pharmaceuticals, Inc.
$58.02 from Allergan Inc.
$56.83 from Kowa Pharmaceuticals America, Inc.
$37.16 from Valeritas, Inc.
Payments received by Dr. Michael Piansky, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!